MKI67 and neoplasm: The xenograft tumor phenotype was further evidenced by a reduction in tumor volume after YTHDF1 knockdown (Fig. 2O), alongside a significant decrease in the Ki67 staining positive rate, as determined by immunohistochemistry (IHC) staining (Fig. 2P–Q).